PET scans guide new drug combo in fight against early Hodgkin's
NCT ID NCT03233347
Summary
This study is testing a personalized treatment plan for adults with early-stage Hodgkin lymphoma. It uses a PET scan after initial chemotherapy to decide if patients need additional immunotherapy. The goal is to control the cancer effectively while aiming to reduce side effects compared to older standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANN ARBOR STAGE IB HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carolinas Medical Center/Levine Cancer Institute
Charlotte, North Carolina, 28203, United States
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
-
University of Washington Medical Center - Montlake
Seattle, Washington, 98195, United States
-
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.